Author Archives: admin

Promethera Biosciences successfully enrolls twenty patients in its multicentric Phase I/II trial

Promethera Biosciences has conducted the trial in Belgium, France, United …

Continue reading

Promethera Biosciences treats first patients with Promethera® HepaStem

Mont-Saint-Guibert, Belgium, May 14 2012 – Promethera Biosciences, a Belgian biotechnology Company developing Promethera® HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and Urea Cycle Disorders, today announces it has treated its first two patients with its innovative treatment based on allogeneic adult liver stem cell technology (HepaStem). These patients were treated and are followed at the Cliniques
Universitaires Saint-Luc (Brussels, Belgium).

Continue reading

More news